Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1147 | 1034 | 1127 | 1395 | 1903 | 2044 |
| Fund Return | 14.71% | 3.41% | 12.67% | 11.73% | 13.73% | 7.41% |
| Place in category | 46 | 394 | 69 | 179 | 215 | 228 |
| % in Category | 10 | 66 | 22 | 43 | 49 | 85 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| LU0090841692 | 1.36B | 21.16 | 18.60 | 8.38 | ||
| LU0329592538 | 1.26B | 16.59 | 14.15 | 7.10 | ||
| LU0147395726 | 372.01M | 14.68 | 11.89 | 4.98 | ||
| Global Allocation Fund X4 USD | 522.55M | 17.51 | 15.23 | 8.13 | ||
| Global Allocation Fund J2 USD | 18.76M | 17.54 | 15.25 | 8.13 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Robeco BP US Premium Equities F $ | 5.78B | 12.20 | 11.35 | 9.73 | ||
| Robeco BP US Premium Equities K $ | 5.78B | 10.21 | 12.41 | 10.10 | ||
| Robeco BP US Premium Equities I $ | 5.78B | 7.15 | 12.41 | 9.26 | ||
| LU0226953718 | 5.78B | 6.68 | 11.42 | 8.30 | ||
| LU2216803838 | 5.78B | 7.20 | 12.51 | - |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| BlackRock ICS USD LiqEnvtlyAwr Agcy Inc | IE00BK8MB266 | 4.01 | - | - | |
| Wells Fargo&Co | US9497461015 | 3.40 | 90.21 | +0.96% | |
| Citigroup | US1729674242 | 3.37 | 107.79 | +1.00% | |
| Cardinal Health | US14149Y1082 | 2.98 | 199.19 | -0.26% | |
| Amazon.com | US0231351067 | 2.77 | 229.11 | -1.41% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Buy | Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review